Search

Your search keyword '"Mulholland AJ"' showing total 243 results

Search Constraints

Start Over You searched for: Author "Mulholland AJ" Remove constraint Author: "Mulholland AJ"
243 results on '"Mulholland AJ"'

Search Results

5. Dynamical responses predict a distal site that modulates activity in an antibiotic resistance enzyme.

6. Biocatalytic pathways, cascades, cells and systems: general discussion.

7. Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against Mycobacterium tuberculosis and Hit Validation by Biological Assays.

8. Multilevel quantum mechanical calculations show the role of promoter molecules in the dehydration of methanol to dimethyl ether in H-ZSM-5.

9. Signal Propagation in the ATPase Domain of Mycobacterium tuberculosis DNA Gyrase from Dynamical-Nonequilibrium Molecular Dynamics Simulations.

10. Sire: An interoperability engine for prototyping algorithms and exchanging information between molecular simulation programs.

11. Electric Fields Are a Key Determinant of Carbapenemase Activity in Class A β-Lactamases.

12. Helicobacter pylori glycan biosynthesis modulates host immune cell recognition and response.

13. Cooperative Conformational Transitions Underpin the Activation Heat Capacity in the Temperature Dependence of Enzyme Catalysis.

14. Decrypting Allostery in Membrane-Bound K-Ras4B Using Complementary In Silico Approaches Based on Unbiased Molecular Dynamics Simulations.

15. Fluctuation Relations to Calculate Protein Redox Potentials from Molecular Dynamics Simulations.

16. Epistasis arises from shifting the rate-limiting step during enzyme evolution of a β-lactamase.

17. Interactive molecular dynamics in virtual reality for modelling materials and catalysts.

18. In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.

19. Free energy along drug-protein binding pathways interactively sampled in virtual reality.

20. Enhancement by pyrazolones of colistin efficacy against mcr-1-expressing E. coli: an in silico and in vitro investigation.

21. SARS-CoV-2 spike variants differ in their allosteric responses to linoleic acid.

22. Heme binding to the SARS-CoV-2 spike glycoprotein.

23. An expandable, modular de novo protein platform for precision redox engineering.

24. Dynamical Nonequilibrium Molecular Dynamics Simulations Identify Allosteric Sites and Positions Associated with Drug Resistance in the SARS-CoV-2 Main Protease.

26. Bioisosteric Design Identifies Inhibitors of Mycobacterium tuberculosis DNA Gyrase ATPase Activity.

27. Tautomer-Specific Deacylation and Ω-Loop Flexibility Explain the Carbapenem-Hydrolyzing Broad-Spectrum Activity of the KPC-2 β-Lactamase.

28. Pyrazolones Potentiate Colistin Activity against MCR-1-Producing Resistant Bacteria: Computational and Microbiological Study.

29. #COVIDisAirborne: AI-enabled multiscale computational microscopy of delta SARS-CoV-2 in a respiratory aerosol.

30. Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity.

31. A Functional Interaction Between Y674-R685 Region of the SARS-CoV-2 Spike Protein and the Human α7 Nicotinic Receptor.

32. In silico design of novel quinazoline-based compounds as potential Mycobacterium tuberculosis PknB inhibitors through 2D and 3D-QSAR, molecular dynamics simulations combined with pharmacokinetic predictions.

33. QM/MM Simulations Reveal the Determinants of Carbapenemase Activity in Class A β-Lactamases.

34. Generalized Born Implicit Solvent Models Do Not Reproduce Secondary Structures of De Novo Designed Glu/Lys Peptides.

35. The emerging potential of interactive virtual reality in drug discovery.

36. Discovery of novel and potent InhA inhibitors by an in silico screening and pharmacokinetic prediction.

37. Multiscale Simulations Identify Origins of Differential Carbapenem Hydrolysis by the OXA-48 β-Lactamase.

38. Identification of Potent DNA Gyrase Inhibitors Active against Mycobacterium tuberculosis .

39. A multiscale approach to predict the binding mode of metallo beta-lactamase inhibitors.

40. QM/MM Molecular Modeling Reveals Mechanism Insights into Flavin Peroxide Formation in Bacterial Luciferase.

41. Mechanistic Insights into the Ligand-Induced Unfolding of an RNA G-Quadruplex.

42. Structural insights in cell-type specific evolution of intra-host diversity by SARS-CoV-2.

43. Impact of Warhead Modulations on the Covalent Inhibition of SARS-CoV-2 M pro Explored by QM/MM Simulations.

44. Crystallography and QM/MM Simulations Identify Preferential Binding of Hydrolyzed Carbapenem and Penem Antibiotics to the L1 Metallo-β-Lactamase in the Imine Form.

45. The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour.

46. Multiscale Workflow for Modeling Ligand Complexes of Zinc Metalloproteins.

47. Exploring human-guided strategies for reaction network exploration: Interactive molecular dynamics in virtual reality as a tool for citizen scientists.

48. Evolution of dynamical networks enhances catalysis in a designer enzyme.

49. Exploration of the structural requirements of Aurora Kinase B inhibitors by a combined QSAR, modelling and molecular simulation approach.

50. Rigidifying a De Novo Enzyme Increases Activity and Induces a Negative Activation Heat Capacity.

Catalog

Books, media, physical & digital resources